Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Stewart, Jonathan W.
Quitkin, Frederic
Fyer, Abby
Rifkin, Arthur
McGrath, Patrick
Liebowitz, Michael
Rosnick, Lyle
and
Klein, Donald F.
1980.
Efficacy of desipramine in endogenomorphically depressed patients.
Journal of Affective Disorders,
Vol. 2,
Issue. 3,
p.
165.
ÅBerg‐Wistedt, A.
1982.
A double–blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression.
Acta Psychiatrica Scandinavica,
Vol. 66,
Issue. 1,
p.
50.
Mindham, R.H.
1982.
Drugs in Psychiatric Practice.
p.
177.
Stewart, Jonathan W.
1985.
Combined use of TCAs and MAOIs.
Psychosomatics,
Vol. 26,
Issue. 11,
p.
879.
Quitkin, Frederick M.
1985.
The Importance of Dosage in Prescribing Antidepressants.
British Journal of Psychiatry,
Vol. 147,
Issue. 6,
p.
593.
Mitchell, Philip
1987.
The Pharmacological Treatment of Tricyclic-Resistant Depression: Review and Management Guidelines.
Australian & New Zealand Journal of Psychiatry,
Vol. 21,
Issue. 4,
p.
442.
Shaw, D. M.
1988.
Psychopharmacology: Current Trends.
p.
118.
Chalmers, Julie S.
and
Cowen, Philip J.
1990.
Drug Treatment of Tricyclic Resistant Depression.
International Review of Psychiatry,
Vol. 2,
Issue. 2,
p.
239.
Quitkin, F. M.
1992.
Methodology of measuring the efficacy of antidepressants.
Psychopharmacology,
Vol. 106,
Issue. S1,
p.
S87.
Laux, G.
Breyer-Pfaff, U.
Delini-Stula, A.
Riederer, P.
König, W.
Fritze, J.
Dietmaier, O.
and
Hebenstreit, G.
1993.
Neuro-Psychopharmaka.
p.
11.
Schmauss, M.
1993.
Alte und neue Medikamente in der psychiatrischen Therapie.
p.
73.
Little, J. D.
1995.
Effect of Recommended Dosage Range on the Prescribing of Antidepressants.
Australian & New Zealand Journal of Psychiatry,
Vol. 29,
Issue. 2,
p.
304.
Quitkin, F. M.
and
Klein, D. F.
1998.
[No Title].
British Journal of Psychiatry,
Vol. 173,
Issue. 2,
p.
181.
Kuhs, H
Kemper, B
Lippe-Neubauer, U
Meyer-Dunker, J
and
Tölle, R
1998.
Repeated sleep deprivation once versus twice a week in combination with amitriptyline.
Journal of Affective Disorders,
Vol. 47,
Issue. 1-3,
p.
97.
Laux, G.
Fritze, J.
König, W.
Dietmaier, O.
and
König, F.
2002.
Neuro-Psychopharmaka Ein Therapie-Handbuch.
p.
103.
Fava, Maurizio
Rush, A.John
Trivedi, Madhukar H
Nierenberg, Andrew A
Thase, Michael E
Sackeim, Harold A
Quitkin, Frederic M
Wisniewski, Steven
Lavori, Philip W
Rosenbaum, Jerrold F
Kupfer, David J
and
for the STAR∗D Investigators Group
2003.
Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR∗D) study.
Psychiatric Clinics of North America,
Vol. 26,
Issue. 2,
p.
457.
Baghai
Rupprecht
Möller
Adli
Bauer
Grunze
Scharfetter
Schäfer
Conca
Riedel
Strassnig
Möller
Müller
Müller-Siecheneder
Praschak-Rieder
and
Willeit
2004.
Elektrokonvulsionstherapie.
p.
343.
Adli, M.
Baethge, Ch.
Heinz, A.
Langlitz, N.
and
Bauer, M.
2005.
Is dose escalation of antidepressants a rational strategy after a medium–dose treatment has failed?.
European Archives of Psychiatry and Clinical Neuroscience,
Vol. 255,
Issue. 6,
p.
387.
Stewart, Jonathan W.
Mcgrath, Patrick J.
Deliyannides, Rodeborah A.
and
Quitkin, Frederic M.
2009.
Does Dual Antidepressant Therapy as Initial Treatment Hasten and Increase Remission from Depression?.
Journal of Psychiatric Practice,
Vol. 15,
Issue. 5,
p.
337.
McGrath, Patrick J.
and
Miller, Jeffrey M.
2015.
Psychiatry.
p.
2311.